| New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes | | monomer | 27-642 | 99.83 | 1×NAG; 1×H62; 2×NAG; 2×GOL; 1×TLA; 1×CL; |
|
| Human alpha-l-iduronidase | | monomer | 27-642 | 100 | 1×NAG; 1×NAG; 1×NAG; 3×TLA; 1×GOL; 1×PO4; 1×CL; |
|
| New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes | | monomer | 27-642 | 99.83 | 1×NAG; 1×NAG; 1×NAG; 1×H6B; 7×GOL; 1×TLA; 1×CL; |
|
| Human alpha-L-iduronidase in complex with iduronic acid | | monomer | 27-642 | 100 | 1×NAG; 1×NAG; 1×NAG; 1×IDR; 1×PO4; 1×CL; |
|
| Human iduronidase apo structure P21 form | | monomer | 27-640 | 99.67 | 1×NAG; 3×GOL; 2×NAG; 1×CL; |
|
| Crystal structure of apo-iduronidase in the R3 form | | monomer | 28-640 | 99.83 | 1×NAG; 1×NAG; 1×NAG; 1×GOL; 1×CL; |
|
| Crystal structure of human alpha-L-iduronidase in the P212121 form | | monomer | 28-640 | 99.66 | 1×NAG; 2×NAG; 6×GOL; 1×CL; 1×SO4; |
|
| Crystal structure of human alpha-L-iduronidase complex with 2-deoxy-2-fluoro-alpha-L-idopyranosylur… | | monomer | 28-640 | 99.83 | 1×NAG; 1×NAG; 1×NAG; 2×GOL; 1×FIF; 1×CL; |
|
| Crystal structure of human alpha-L-iduronidase complex with alpha-L-iduronic acid | | monomer | 28-640 | 99.83 | 1×NAG; 1×NAG; 1×NAG; 3×GOL; 1×TLA; 1×IDR; 1×CL; 1×SO4; |
|
| Crystal structure of human alpha-L-iduronidase complex with [2R,3R,4R,5S]-2-carboxy-3,4,5-trihydrox… | | monomer | 28-640 | 99.83 | 1×NAG; 1×NAG; 1×NAG; 1×GOL; 1×IDJ; |
|
| Crystal structure of human alpha-L-iduronidase complex with 5-fluoro-alpha-L-idopyranosyluronic aci… | | monomer | 28-640 | 99.83 | 1×NAG; 1×NAG; 1×NAG; 2×GOL; 1×IDF; |
|